Skip Nav Destination
Issues
1 November 2012
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Commentary
Closed-Loop Systems: Diversity and Natural Selection
Diabetes Care October 2012, Vol.35, 2111-2112. doi:https://doi.org/10.2337/dc12-1443
Original Research
Health Insurance Coverage Among People With and Without Diabetes in the U.S. Adult Population
Diabetes Care October 2012, Vol.35, 2243-2249. doi:https://doi.org/10.2337/dc12-0257
Clinical Care / Education / Nutrition / Psychosocial Research
Superficial Wound Swabbing: A novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations
Michael Schmohl, PHD; Stefan Beckert, MD; Thomas O. Joos, PHD; Alfred Königsrainer, MD; Nicole Schneiderhan-Marra, PHD; Markus W. Löffler, MD
Diabetes Care October 2012, Vol.35, 2113-2120. doi:https://doi.org/10.2337/dc11-2547
Curcumin Extract for Prevention of Type 2 Diabetes
Somlak Chuengsamarn, MD; Suthee Rattanamongkolgul, MD; Rataya Luechapudiporn, PHD; Chada Phisalaphong, PHD; Siwanon Jirawatnotai, PHD
Diabetes Care October 2012, Vol.35, 2121-2127. doi:https://doi.org/10.2337/dc12-0116
Monitoring of Individual Needs in Diabetes (MIND)-2: Follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study
Frank J. Snoek, PHD; Nancy Y.A. Kersch, MSC; Ebbe Eldrup, MD; Ilana Harman-Boehm, MD; Norbert Hermanns, PHD; Andrzej Kokoszka, MD; David R. Matthews, MD; Brian E. McGuire, PHD; Mirjana Pibernik-Okanović, PHD; Joelle Singer, MD; Maartje de Wit, PHD; Søren E. Skovlund, MSC
Diabetes Care October 2012, Vol.35, 2128-2132. doi:https://doi.org/10.2337/dc11-1326
Efficacy of Metabolic and Psychological Screening for Mood Disorders Among Children With Type 1 Diabetes
Agnieszka Butwicka, MD; Wojciech Fendler, MD; Adam Zalepa, MA; Agnieszka Szadkowska, MD; Beata Mianowska, MD; Agnieszka Gmitrowicz, MD; Wojciech Młynarski, MD
Diabetes Care October 2012, Vol.35, 2133-2139. doi:https://doi.org/10.2337/dc12-0160
A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes
Richard M. Bergenstal, MD; Julio Rosenstock, MD; Richard F. Arakaki, MD; Melvin J. Prince, MD; Yongming Qu, PHD; Vikram P. Sinha, PHD; Daniel C. Howey, MD; Scott J. Jacober, DO
Diabetes Care October 2012, Vol.35, 2140-2147. doi:https://doi.org/10.2337/dc12-0060
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas
Steven J. Russell, MD; Firas H. El-Khatib, PHD; David M. Nathan, MD; Kendra L. Magyar, MSN; John Jiang, BS; Edward R. Damiano, PHD
Diabetes Care October 2012, Vol.35, 2148-2155. doi:https://doi.org/10.2337/dc12-0071
Intervention Costs and Cost-Effectiveness of a Successful Telephonic Intervention to Promote Diabetes Control
Diabetes Care October 2012, Vol.35, 2156-2160. doi:https://doi.org/10.2337/dc12-0048
Psychometric Evaluation of the Adherence in Diabetes Questionnaire
Lene J. Kristensen, MSC; Mikael Thastum, PHD; Anne H. Mose, MSC; Niels H. Birkebaek, PHD; the Danish Society for Diabetes in Childhood and Adolescence
Diabetes Care October 2012, Vol.35, 2161-2166. doi:https://doi.org/10.2337/dc11-2342
White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study
Tandy Aye, MD; Naama Barnea-Goraly, MD; Christian Ambler, PHD; Sherry Hoang, PHD; Kristin Schleifer, PHD; Yaena Park, BS; Jessica Drobny, MS; Darrell M. Wilson, MD; Allan L. Reiss, MD; Bruce A. Buckingham, MD
Diabetes Care October 2012, Vol.35, 2167-2173. doi:https://doi.org/10.2337/dc12-0017
Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
Irl B. Hirsch, MD; Bruce Bode, MD; Jean-Pierre Courreges, MD; Patrik Dykiel, MSC; Edward Franek, MD; Kjeld Hermansen, MD; Allen King, MD; Henriette Mersebach, MD; Melanie Davies, MD
Diabetes Care October 2012, Vol.35, 2174-2181. doi:https://doi.org/10.2337/dc11-2503
The Use of an Automated, Portable Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes
Michael J. O'Grady, MBBCH; Adam J. Retterath, BSC; D. Barry Keenan, PHD; Natalie Kurtz, PHD; Martin Cantwell, BSC; Glenn Spital, BSC; Michael N. Kremliovsky, PHD; Anirban Roy, PHD; Elizabeth A. Davis, PHD; Timothy W. Jones, MD; Trang T. Ly, MBBS
Diabetes Care October 2012, Vol.35, 2182-2187. doi:https://doi.org/10.2337/dc12-0761
A Learner-Centered Diabetes Management Curriculum: Reducing resident errors on an inpatient diabetes pathway
Diabetes Care October 2012, Vol.35, 2188-2193. doi:https://doi.org/10.2337/dc12-0450
Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
Young-Hoon Jeong, MD; Udaya S. Tantry, PHD; Yongwhi Park, MD; Tae Jung Kwon, MD; Jeong Rang Park, MD; Seok-Jae Hwang, MD; Kevin P. Bliden, MBA; Eun-Ha Koh, MD; Choong Hwan Kwak, MD; Jin-Yong Hwang, MD; Sunjoo Kim, MD; Paul A. Gurbel, MD
Diabetes Care October 2012, Vol.35, 2194-2197. doi:https://doi.org/10.2337/dc11-2351
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes
Sunder Mudaliar, MD; Debra A. Armstrong, BA; Annie A. Mavian, MD; Robin O’Connor-Semmes, PHD; Patricia K. Mydlow, BS; June Ye, PHD; Elizabeth K. Hussey, PHARMD; Derek J. Nunez, MD; Robert R. Henry, MD; Robert L. Dobbins, MD
Diabetes Care October 2012, Vol.35, 2198-2200. doi:https://doi.org/10.2337/dc12-0508
Epidemiology / Health Services Research
Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study
Jamie Morton, MBBS; Sophia Zoungas, PHD; Qiang Li, MBIOSTAT; Anushka A. Patel, PHD; John Chalmers, PHD; Mark Woodward, PHD; David S. Celermajer, PHD; Joline W.J. Beulens, PHD; Ronald P. Stolk, PHD; Paul Glasziou, PHD; Martin K.C. Ng, PHD; on behalf of the ADVANCE Collaborative Group
Diabetes Care October 2012, Vol.35, 2201-2206. doi:https://doi.org/10.2337/dc12-0306
Effect of Intensive Multifactorial Treatment Compared With Routine Care on Aortic Stiffness and Central Blood Pressure Among Individuals With Screen-Detected Type 2 Diabetes: The ADDITION-Denmark study
Nanna B. Johansen, MD; Morten Charles, MD; Dorte Vistisen, PHD; Signe S. Rasmussen, PHD; Niels Wiinberg, MD; Knut Borch-Johnsen, DRMEDSCI; Torsten Lauritzen, DRMEDSCI; Annelli Sandbæk, PHD; Daniel R. Witte, PHD
Diabetes Care October 2012, Vol.35, 2207-2214. doi:https://doi.org/10.2337/dc12-0176
Breast-Feeding and Childhood-Onset Type 1 Diabetes: A pooled analysis of individual participant data from 43 observational studies
Chris R. Cardwell, PHD; Lars C. Stene, PHD; Johnny Ludvigsson, MD; Joachim Rosenbauer, MD; Ondrej Cinek, MD; Jannet Svensson, PHD; Francisco Perez-Bravo, PHD; Anjum Memon, MBBS; Suely G. Gimeno, DPH; Emma J.K. Wadsworth, PHD; Elsa S. Strotmeyer, PHD; Michael J. Goldacre, FFPHM; Katja Radon, PHD; Lee-Ming Chuang, MD; Roger C. Parslow, PHD; Amanda Chetwynd, PHD; Kyriaki Karavanaki, MD; Girts Brigis, MD; Paolo Pozzilli, MBBS; Brone UrbonaitĖ, MD; Edith Schober, MD; Gabriele Devoti, MD; Sandra Sipetic, MD; Geir Joner, MD; Constantin Ionescu-Tirgoviste, MD; Carine E. de Beaufort, MD; Kirsten Harrild, MSC; Victoria Benson, PHD; Erkki Savilahti, MD; Anne-Louise Ponsonby, MBBS; Mona Salem, MD; Samira Rabiei, MSC; Chris C. Patterson, PHD
Diabetes Care October 2012, Vol.35, 2215-2225. doi:https://doi.org/10.2337/dc12-0438
Determinants of Racial/Ethnic Disparities in Incidence of Diabetes in Postmenopausal Women in the U.S.: The Women’s Health Initiative 1993–2009
Yunsheng Ma, MD; James R. Hébert, MSPH; JoAnn E. Manson, MD; Raji Balasubramanian, SCD; Simin Liu, MD; Michael J. Lamonte, PHD; Chloe E. Bird, PHD; Judith K. Ockene, PHD; Yongxia Qiao, MD; Barbara Olendzki, RD; Kristin L. Schneider, PHD; Milagros C. Rosal, PHD; Deidre M. Sepavich, MBA; Jean Wactawski-Wende, PHD; Marcia L. Stefanick, PHD; Lawrence S. Phillips, MD; Ira S. Ockene, MD; Robert C. Kaplan, PHD; Gloria E. Sarto, MD; Lorena Garcia, DRPH; Barbara V. Howard, PHD
Diabetes Care October 2012, Vol.35, 2226-2234. doi:https://doi.org/10.2337/dc12-0412
Periodontal Infection, Systemic Inflammation, and Insulin Resistance: Results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999–2004
Ryan T. Demmer, PHD; Anthony Squillaro, MPH; Panos N. Papapanou, DDS; Michael Rosenbaum, MD; William T. Friedewald, MD; David R. Jacobs, Jr., PHD; Moïse Desvarieux, MD
Diabetes Care October 2012, Vol.35, 2235-2242. doi:https://doi.org/10.2337/dc12-0072
Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans: Results from Translating Research Into Action for Diabetes (TRIAD)
Ping Zhang, PHD; Morton B. Brown, PHD; Dori Bilik, MBA; Ronald T. Ackermann, MD; Rui Li, PHD; William H. Herman, MD
Diabetes Care October 2012, Vol.35, 2250-2256. doi:https://doi.org/10.2337/dc11-2478
Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes
Gillian L. Booth, MD; Phoebe Bishara, MD; Lorraine L. Lipscombe, MD; Baiju R. Shah, MD; Denice S. Feig, MD; Onil Bhattacharyya, MD; Arlene S. Bierman, MD
Diabetes Care October 2012, Vol.35, 2257-2264. doi:https://doi.org/10.2337/dc12-0364
Alternative Markers of Hyperglycemia and Risk of Diabetes
Diabetes Care October 2012, Vol.35, 2265-2270. doi:https://doi.org/10.2337/dc12-0787
Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes: The PPP-Botnia Study
Antti-Jussi Pyykkönen, MA; Bo Isomaa, MD; Anu-Katriina Pesonen, PHD; Johan G. Eriksson, MD; Leif Groop, MD; Tiinamaija Tuomi, MD; Katri Räikkönen, PHD
Diabetes Care October 2012, Vol.35, 2271-2278. doi:https://doi.org/10.2337/dc12-0348
Estimation of Expected Life-Years Saved From Successful Prevention of End-Stage Renal Disease in Elderly Patients With Diabetes: A nationwide study from Taiwan
Deng-Chi Yang, MD; Lukas Jyuhn-Hsiarn Lee, MD; Chih-Cheng Hsu, MD; Yu-Yin Chang, MSC; Ming-Cheng Wang, MD; Wei-Hung Lin, MD; Chia-Ming Chang, MD; Jung-Der Wang, MD
Diabetes Care October 2012, Vol.35, 2279-2285. doi:https://doi.org/10.2337/dc12-0545
Poverty Increases Type 2 Diabetes Incidence and Inequality of Care Despite Universal Health Coverage
Chih-Cheng Hsu, MD; Cheng-Hua Lee, MD; Mark L. Wahlqvist, MD; Hsiao-Ling Huang, DRPH; Hsing-Yi Chang, DRPH; Likwang Chen, PHD; Shu-Fang Shih, PHD; Shyi-Jang Shin, MD; Wen-Chen Tsai, DRPH; Ted Chen, PHD; Chi-Ting Huang, MS; Jur-Shan Cheng, PHD
Diabetes Care October 2012, Vol.35, 2286-2292. doi:https://doi.org/10.2337/dc11-2052
Mortality Among Low-Income African Americans and Whites With Diabetes
Diabetes Care October 2012, Vol.35, 2293-2299. doi:https://doi.org/10.2337/dc11-2495
Cyclical Variation in the Incidence of Childhood Type 1 Diabetes in Western Australia (1985–2010)
Aveni Haynes, MBBCHIR; Max K. Bulsara, PHD; Carol Bower, PHD; Timothy W. Jones, MD; Elizabeth A. Davis, FRACP
Diabetes Care October 2012, Vol.35, 2300-2302. doi:https://doi.org/10.2337/dc12-0205
Pathophysiology / Complications
Altered Phenotype of Peripheral Blood Dendritic Cells in Pediatric Type 1 Diabetes
Janne K. Nieminen, MD; Jukka Vakkila, MD; Harri M. Salo, PHD; Nina Ekström, MSC; Taina Härkönen, PHD; Jorma Ilonen, MD; Mikael Knip, MD; Outi Vaarala, MD
Diabetes Care October 2012, Vol.35, 2303-2310. doi:https://doi.org/10.2337/dc11-2460
Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
Andrzej S. Krolewski, MD; James H. Warram, MD; Carol Forsblom, DMSC; Adam M. Smiles, MS; Lena Thorn, MD; Jan Skupien, MD; Valma Harjutsalo, PHD; Robert Stanton, MD; John H. Eckfeldt, MD; Lesley A. Inker, MD; Per-Henrik Groop, MD
Diabetes Care October 2012, Vol.35, 2311-2316. doi:https://doi.org/10.2337/dc11-2220
Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study
Giuseppe Penno, MD; Anna Solini, MD; Giacomo Zoppini, MD; Emanuela Orsi, MD; Gianpaolo Zerbini, MD; Roberto Trevisan, MD; Gabriella Gruden, MD; Franco Cavalot, MD; Luigi Laviola, MD; Susanna Morano, MD; Antonio Nicolucci, MD; Giuseppe Pugliese, MD; for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group
Diabetes Care October 2012, Vol.35, 2317-2323. doi:https://doi.org/10.2337/dc12-0628
The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes
David Z.I. Cherney, MD; James W. Scholey, MD; Shan Jiang, BMSC; Ronnie Har, BSC; Vesta Lai, RN; Etienne B. Sochett, MBBCH; Heather N. Reich, MD
Diabetes Care October 2012, Vol.35, 2324-2330. doi:https://doi.org/10.2337/dc12-0773
Skin Intrinsic Fluorescence Is Associated With Coronary Artery Disease in Individuals With Long Duration of Type 1 Diabetes
Baqiyyah N. Conway, PHD; Vanita R. Aroda, MD; John D. Maynard, MS; Nathaniel Matter, PHD; Stephen Fernandez, MPH; Robert E. Ratner, MD; Trevor J. Orchard, MD
Diabetes Care October 2012, Vol.35, 2331-2336. doi:https://doi.org/10.2337/dc12-0053
Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes
Filippo Valbusa, MD; Stefano Bonapace, MD; Lorenzo Bertolini, MD; Luciano Zenari, MD; Guido Arcaro, MD; Giovanni Targher, MD
Diabetes Care October 2012, Vol.35, 2337-2339. doi:https://doi.org/10.2337/dc12-0314
Cardiovascular and Metabolic Risk
Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
Merel E. Hellemons, MD; Magdalena Mazagova, PHD; Ron T. Gansevoort, MD; Robert H. Henning, MD; Dick de Zeeuw, MD; Stephan J.L. Bakker, MD; Hiddo J. Lambers-Heerspink, PHD; Leo E. Deelman, PHD
Diabetes Care October 2012, Vol.35, 2340-2346. doi:https://doi.org/10.2337/dc12-0180
Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
Giovanni Targher, MD; Giacomo Zoppini, MD; William Mantovani, MD; Michel Chonchol, MD; Carlo Negri, MD; Vincenzo Stoico, MD; Alessandro Mantovani, MD; Francesca De Santi, MD; Enzo Bonora, MD
Diabetes Care October 2012, Vol.35, 2347-2353. doi:https://doi.org/10.2337/dc12-0259
Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
Iefke Drion, MD; Nanne Kleefstra, MD; Gijs W.D. Landman, MD; Alaa Alkhalaf, MD; Joachim Struck, PHD; Klaas H. Groenier, PHD; Stephan J.L. Bakker, MD; Henk J.G. Bilo, MD
Diabetes Care October 2012, Vol.35, 2354-2358. doi:https://doi.org/10.2337/dc11-2526
Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome: Relationships with coronary artery calcium in 10,153 people
Diabetes Care October 2012, Vol.35, 2359-2364. doi:https://doi.org/10.2337/dc12-0515
Transthyretin Predicts Cardiovascular Outcome in Hemodialysis Patients With Type 2 Diabetes
Andrea Henze, PHD; Katharina M. Espe, MSC; Christoph Wanner, MD; Vera Krane, MD; Jens Raila, DMV; Berthold Hocher, MD; Florian J. Schweigert, DMV; Christiane Drechsler, MD
Diabetes Care October 2012, Vol.35, 2365-2372. doi:https://doi.org/10.2337/dc12-0455
Myeloperoxidase Is an Early Biomarker of Inflammation and Cardiovascular Risk in Prepubertal Obese Children
Josune Olza, PHD; Concepcion M. Aguilera, PHD; Mercedes Gil-Campos, PHD; Rosaura Leis, PHD; Gloria Bueno, PHD; Maria D. Martínez-Jiménez, PHD; Miguel Valle, PHD; Ramon Cañete, PHD; Rafael Tojo, PHD; Luis A. Moreno, PHD; Angel Gil, PHD
Diabetes Care October 2012, Vol.35, 2373-2376. doi:https://doi.org/10.2337/dc12-0614
Pancreatic Steatosis and Its Relationship to β-Cell Dysfunction in Humans: Racial and ethnic variations
Lidia S. Szczepaniak, PHD; Ronald G. Victor, MD; Ruchi Mathur, MD; Michael D. Nelson, PHD; Edward W. Szczepaniak, PHD; Nicole Tyer, MD; Ida Chen, PHD; Roger H. Unger, MD; Richard N. Bergman, PHD; Ildiko Lingvay, MD
Diabetes Care October 2012, Vol.35, 2377-2383. doi:https://doi.org/10.2337/dc12-0701
Obstructive Sleep Apnea in Young Lean Men: Impact on insulin sensitivity and secretion
Sushmita Pamidi, MD; Kristen Wroblewski, MSC; Josiane Broussard, PHD; Andrew Day, BSC; Erin C. Hanlon, PHD; Varghese Abraham, MD; Esra Tasali, MD
Diabetes Care October 2012, Vol.35, 2384-2389. doi:https://doi.org/10.2337/dc12-0841
Progression of Vascular Calcification Is Increased With Statin Use in the Veterans Affairs Diabetes Trial (VADT)
Diabetes Care October 2012, Vol.35, 2390-2392. doi:https://doi.org/10.2337/dc12-0464
National Standards
National Standards for Diabetes Self-Management Education and Support
Linda Haas, PHC, RN, CDE; Melinda Maryniuk, MED, RD, CDE; Joni Beck, PHARMD, CDE, BC-ADM; Carla E. Cox, PHD, RD, CDE, CSSD; Paulina Duker, MPH, RN, BC-ADM, CDE; Laura Edwards, RN, MPA; Edwin B. Fisher, PHD; Lenita Hanson, MD, CDE, FACE, FACP; Daniel Kent, PHARMD, BS, CDE; Leslie Kolb, RN, BSN, MBA; Sue McLaughlin, BS, RD, CDE, CPT; Eric Orzeck, MD, FACE, CDE; John D. Piette, PHD; Andrew S. Rhinehart, MD, FACP, CDE; Russell Rothman, MD, MPP; Sara Sklaroff; Donna Tomky, MSN, RN, C-NP, CDE, FAADE; Gretchen Youssef, MS, RD, CDE; on behalf of the 2012 Standards Revision Task Force
Diabetes Care October 2012, Vol.35, 2393-2401. doi:https://doi.org/10.2337/dc12-1707
Reviews / Commentaries / ADA Statements
Meta-analysis
Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis
Katherine Esposito, MD; Paolo Chiodini, PHD; Annamaria Colao, MD; Andrea Lenzi, MD; Dario Giugliano, MD
Diabetes Care October 2012, Vol.35, 2402-2411. doi:https://doi.org/10.2337/dc12-0336
Errata
Health-related quality of life among German youths with early-onset and long-duration type 1 diabetes. Diabetes Care 2012;35:1736–1742
Diabetes Care October 2012, Vol.35, 2412. doi:https://doi.org/10.2337/dc12-er11a
Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 2012;35:80–86
J Rosenbauer; A Dost; B Karges; A Hungele; A Stahl; C Bächle; EM Gerstl; C Kastendieck; SE Hofer; RW Holl; on behalf of the DPV Initiative and the German BMBF Competence Network Diabetes Mellitus
Diabetes Care October 2012, Vol.35, 2412. doi:https://doi.org/10.2337/dc12-er11b
Issues and Events
Online Letters: Observations
Incretin Effect of Glucagon-Like Peptide 1 Receptor Agonist Is Preserved in Presence of ABCC8/SUR1 Mutation in β-Cell
Olivier Bourron, MD, PHD; Fatma Chebbi, MD; Marine Halbron, MD; Cécile Saint-Martin, MD; Christine Bellanné-Chantelot, MD, PHD; Ahmed Abed, MD; Beny Charbit, MD, PHD; Christophe Magnan, MD, PHD; J.M. Lacorte, MD, PHD; Agnès Hartemann, MD, PHD
Diabetes Care October 2012, Vol.35, e76. doi:https://doi.org/10.2337/dc12-0535
Incidence of Type 1 Diabetes in Mexico: Data From an Institutional Register 2000–2010
Rita A. Gómez-Díaz, MSC; Gabriela Pérez-Pérez, MD; Irina Tatiana Hernández-Cuesta, MD; Julia del Carmen Rodríguez-García, MD; Raúl Guerrero-López, MD; Carlos A. Aguilar-Salinas, MD; Niels H. Wacher, MD
Diabetes Care October 2012, Vol.35, e77. doi:https://doi.org/10.2337/dc12-0844
Glucose Derangements in Very Young Children With Cystic Fibrosis and Pancreatic Insufficiency
Enza Mozzillo, MD; Valeria Raia, MD; Valentina Fattorusso, MD; Mariateresa Falco, MD; Angela Sepe, MD; Fabiola De Gregorio, MD; Rosa Nugnes, MD; Giuliana Valerio, MD, PHD; Adriana Franzese, MD
Diabetes Care October 2012, Vol.35, e78. doi:https://doi.org/10.2337/dc12-0459
Online Letters: Comments and Responses
Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
Diabetes Care October 2012, Vol.35, e79. doi:https://doi.org/10.2337/dc12-0817
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
David A. Fraser, PHD; Lien M. Diep, MSC; Inger Anette Hovden, MD, PHD; Kristian B. Nilsen, MD, PHD; Kari Anne Sveen, MD; Ingebjørg Seljeflot, PHD; Kristian F. Hanssen, MD, PHD
Diabetes Care October 2012, Vol.35, e80. doi:https://doi.org/10.2337/dc12-1124
